Takeda Pharmaceutical (TAK) Shares Outstanding (Weighted Average): 2019-2025

Historic Shares Outstanding (Weighted Average) for Takeda Pharmaceutical (TAK) over the last 7 years, with Mar 2025 value amounting to $1.6 billion.

  • Takeda Pharmaceutical's Shares Outstanding (Weighted Average) rose 1.04% to $1.6 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $1.6 billion, marking a year-over-year increase of 1.04%. This contributed to the annual value of $1.6 billion for FY2025, which is 1.04% up from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Shares Outstanding (Weighted Average) of $1.6 billion as of FY2025, which was up 1.04% from $1.6 billion recorded in FY2024.
  • Takeda Pharmaceutical's Shares Outstanding (Weighted Average)'s 5-year high stood at $1.6 billion during FY2025, with a 5-year trough of $1.6 billion in FY2023.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $1.6 billion, with a median of $1.6 billion in 2024.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first decreased by 0.83% in 2023, then climbed by 1.20% in 2024.
  • Takeda Pharmaceutical's Shares Outstanding (Weighted Average) (Yearly) stood at $1.6 billion in 2021, then climbed by 0.36% to $1.6 billion in 2022, then dropped by 0.83% to $1.6 billion in 2023, then grew by 1.20% to $1.6 billion in 2024, then rose by 1.04% to $1.6 billion in 2025.